Aptamer Therapeutics Creative Group
Aptamers are a class of molecules that combine advantages of small molecule drugs and biologics. Specially modified aptamers have the potential to leverage recent advances in oligonucleotide technology to radically transform treatment of many diseases. Aptamer Therapeutics Creative Group (ATCG) aims to harness Raptamer™ technology to develop novel therapeutic strategies for conditions such as infectious diseases, autoimmune diseases and cancer.
Contact us for more information.